Answers are grounded in this paper and cite their sources.
Sir, Bordetella bronchiseptica is often involved in respiratory tract infections of farm animals (i.e. pigs and rabbits) and pets (i.e. cats and dogs). Infections in humans are seen mainly in older and immunocompromised patients. Although antimicrobial agents are commonly applied to control B. bronchiseptica infections,1 little is known about the molecular basis of antimicrobial resistance in these bacteria. Although tetracycline resistance in B. bronchiseptica was already described in 1981 to be associated with a non-conjugative plasmid,2 it took until 1997 when the first and so far only tetracycline resistance gene, tet(C), was identified in B. bronchiseptica isolates from cats.3 In the present study, we investigated two isolates from pigs for the molecular basis of tetracycline resistance with particular reference to the type of tet gene present, its location on a mobile genetic element and the possibility of horizontal transfer. A recent survey revealed that tetracycline resistance was seen in <1% of 349 porcine B. bronchiseptica isolates.1 A tetracycline MIC value of 64 mg/L had been reported for the two isolates, nos. 958 and V4037/8.1 PCR screening for tet genes, plasmid profiling, conjugation, cloning and sequencing followed previously described protocols.4,5 PCR confirmed that both B. bronchiseptica isolates carried a tet gene of hybridization class A. Both tet(A)-carrying isolates were subjected to macrorestriction analysis.4 Their XbaI fragment patterns differed by 10 bands and thus confirmed that the two B. bronchiseptica isolates were unrelated.
No takes yet. Share an insight, caveat, or question.
Kristina Kadlec (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: